HIGHLIGHTS
- who: Andre Peeters and colleagues from the Division of Cardiology, Cliniques Universitaires Saint-Luc, Universitu00e9 Catholique Louvain (UCLouvain) have published the research work: Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome, in the Journal: Journal of Interventional Cardiology of 27/Oct/2022
- what: The aim of this study was to compare the long-term outcome in a cohort of consecutive patients undergoing PFO closure after cryptogenic stroke, who received antithrombotic agents for a short (6 months) vs. extended (>6 months) period after the procedure.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.